Dyadic International Inc. (DYAI) vs Neuphoria Therapeutics Inc. (NEUP)
- Dyadic International Inc. DYAI 0.33 −5.71%
- Neuphoria Therapeutics Inc. NEUP 2.55 −1.16%
Dyadic International Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Dyadic International Inc. and Neuphoria Therapeutics Inc. are of similar size ($14.0M and $14.0M). Neuphoria Therapeutics Inc. grew revenue faster over the last twelve months: 3,535.1% against −7.64%. Neuphoria Therapeutics Inc. has the higher net margin (0.00% vs −226.9%) and the lower return on invested capital (−232.7% vs 0.00%). Across the 16 metrics below, Neuphoria Therapeutics Inc. leads on 10 and Dyadic International Inc. on 6.
Valuation
Profitability
| Metric | DYAI | NEUP | Biotechnology median |
|---|---|---|---|
| Gross margin | 17.85% | 0.00% | 67.24% |
| Operating margin | (237.12%) | 0.00% | 0.00% |
| Net margin | (226.87%) | 0.00% | 0.00% |
| Free cash flow margin | (227.93%) | 0.00% | 0.00% |
| Return on equity | (47,310.78%) | (61.70%) | (50.28%) |
| Return on assets | (71.43%) | (46.95%) | (45.89%) |
| Return on invested capital | 0.00% | (232.67%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack